114312-57-1

Basic information

• Product Name: Ethyl 3-Fluoro-2-Methylbenzoate
• Synonyms: Ethyl 3-Fluoro-2-Methylbenzoate;Benzoic acid, 3-fluoro-2-Methyl-, ethyl ester
• CAS NO: 114312-57-1
• Molecular Formula: C₁₀H₁₁FO₂
• Molecular Weight: 182.1915432
• Mol File: 114312-57-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 230.7°C at 760 mmHg
• Flash Point: 90.8°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 0.0648mmHg at 25°C
• Refractive Index: 1.489
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Ethyl 3-Fluoro-2-Methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 3-Fluoro-2-Methylbenzoate(114312-57-1)
• EPA Substance Registry System: Ethyl 3-Fluoro-2-Methylbenzoate(114312-57-1)

Safety Data

• Hazardous Substances Data: 114312-57-1(Hazardous Substances Data)

Usage

General Description

Ethyl 3-fluoro-2-methylbenzoate is a chemical compound with the molecular formula C10H11FO2. It is a colorless liquid with a faint fruity odor, commonly used in the synthesis of pharmaceuticals and agrochemicals. Ethyl 3-Fluoro-2-Methylbenzoate is known for its potential use as a flavor or fragrance agent due to its pleasant aroma. It is also used as an intermediate in the production of various other organic compounds. Ethyl 3-fluoro-2-methylbenzoate has the potential for various industrial applications due to its unique chemical properties.

InChI:InChI=1/C10H11FO2/c1-3-13-10(12)8-5-4-6-9(11)7(8)2/h4-6H,3H2,1-2H3

Upstream product

• 699-90-1 3-fluoro-2-methylbenzoic acid 
• 75-03-6 ethyl iodide 
• 64-17-5 ethanol 

Downstream Products

• 114312-58-2 ethyl 2-(bromomethyl)-3-fluorobenzoate 

Relevant articles and documents

Pyridazone derivative and its uses

The present invention belongs to the pharmaceutical field, specifically relates to a pyridazone derivative and its uses, compounds thereof and pharmaceutically acceptable salts, solvates including hydrates, polycrystallines, prodrugs, co-crystallines, tau

Influenza virus replication inhibitor and uses thereof

The invention belongs to the field of medicines, and particularly relates to a new compound serving as an influenza virus replication inhibitor, a preparation method thereof, a pharmaceutical composition containing the compound, and application of the compound and the pharmaceutical composition in the treatment of influenza. The compound is a compound shown in a formula (I) or a stereoisomer, a tautomer, oxynitride, a solvate, a metabolite, a pharmaceutically acceptable salt or prodrugs of the compound shown in the formula (I). The compound can well inhibit influenza viruses, and/or has lowercytotoxicity, more excellent in-vivo metabolic dynamics properties and in-vivo pharmacodynamic properties.

Novel cyclic amide derivatives

Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH2—, —CO—, —O—, —CH(OR7)— or the like wherein R7 represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R1 and R2 each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups: wherein R3, R4, R5, and R6 each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of: represents an aromatic heterocyclic ring.